ALTRAPHARMA Invest ApS: Financial statements 2014
CVR: 34483884
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 1,396,358 and a net result of DKK 223,261 compared with DKK 145,072 the year before. That is an increase of 1.6% compared with the year before. Equity in the 2014 report amounted to DKK 622,766. The solvency ratio was 66.2%.
- Gross Profit
- DKK 1,396,358
- Profit/Loss
- DKK 223,261
- Equity
- DKK 622,766
- Total Assets
- DKK 940,082
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 1.4 mio. | 223 t. | 623 t. | - |
| 2013 | - | 1.4 mio. | 145 t. | 650 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ALTRAPHARMA Invest ApS has published its annual report for 2013. Gross profit came to DKK 1,373,710, and the net result was DKK 145,072.
About ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.